Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females

被引:37
作者
Pedrini, Marzena J. Fabis [1 ]
Seewann, Alexandra [2 ]
Bennett, Kirsten A. [1 ]
Wood, Alex J. T. [1 ]
James, Ian [3 ]
Burton, Jason [1 ]
Marshall, Barry J. [4 ]
Carroll, William M. [1 ]
Kermode, Allan G. [1 ,3 ]
机构
[1] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Western Australian Neurosci Res Inst, Sir Charles Gairdner Hosp,QEII Med Ctr, Nedlands, WA 6009, Australia
[2] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands
[3] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia
[4] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, QEII Med Ctr, Nedlands, WA 6009, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
NEUROMYELITIS-OPTICA; DISEASE; ASSOCIATION; AUSTRALIA;
D O I
10.1136/jnnp-2014-309495
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background In recent years, a relationship between Helicobacter pylori and many disease conditions has been reported, however, studies in its relationship with multiple sclerosis (MS) have had contradictory results. Objective To determine the association between the H. pylori infection and MS. Methods 550 patients with MS were included in the study and were matched by gender and year of birth to 299 controls. Patients were assessed for clinical and demographic parameters. An enzyme immunoassay was used to detect the presence of specific IgG antibodies against H. pylori in the serum sample of both groups. Results H. pylori seropositivity was found to be lower in the patients with MS than in controls (16% vs 21%) with the decrease pertaining to females (14% vs 22%, p=0.027) but not males (19% vs 20%, p=1.0). When adjusted for age at onset, year of birth and disease duration, H. pylori seropositive females presented with a lower disability score than seronegative females (p=0.049), while among males the reverse was true (p=0.025). There was no significant association between H. pylori seropositivity and relapse rate. Conclusions Our results could reflect a protective role of H. pylori in the disease development. However, it may be that H. pylori infection is a surrogate marker for the 'hygiene hypothesis', a theory which postulates that early life infections are essential to prime the immune system and thus prevent allergic and autoimmune conditions later in life. The fact that the association between H. pylori seropositivity and MS risk was seen almost exclusively in females requires further investigation.
引用
收藏
页码:603 / 607
页数:5
相关论文
共 50 条
  • [31] HELICOBACTER PYLORI AND BARRETT'S ESOPHAGUS: A PROTECTIVE FACTOR OR A REAL CAUSE?
    Tomasello, G.
    Giordano, F.
    Mazzola, M.
    Jurjus, R.
    Jurjus, A.
    Damiani, P.
    Nobile, S.
    Carini, F.
    Leone, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (01) : 9 - 15
  • [32] Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males
    Zhang, Linfang
    Chen, Zhiheng
    Xia, Xiujuan
    Chi, Jingshu
    Li, Huan
    Liu, Xiaoming
    Li, Rong
    Li, Yixi
    Liu, Da
    Tian, Delin
    Wang, Hui
    Petroski, Greg F.
    Flaker, Greg C.
    Hao, Hong
    Liu, Zhenguo
    Xu, Canxia
    ATHEROSCLEROSIS, 2019, 291 : 71 - 77
  • [33] Associations of lung cancer risk with biomarkers of Helicobacter pylori infection
    Yoon, Hyung-Suk
    Shu, Xiao-Ou
    Cai, Hui
    Zheng, Wei
    Wu, Jie
    Wen, Wanqing
    Courtney, Regina
    Shidal, Chris
    Waterboer, Tim
    Blot, William J.
    Cai, Qiuyin
    CARCINOGENESIS, 2022, 43 (06) : 538 - 546
  • [34] Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China
    Weijun Wang
    Mengke Fan
    Rui Gong
    Yurui Zhang
    Junchao Zeng
    Sanping Xu
    Rong Lin
    BMC Gastroenterology, 22
  • [35] Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China
    Wang, Weijun
    Fan, Mengke
    Gong, Rui
    Zhang, Yurui
    Zeng, Junchao
    Xu, Sanping
    Lin, Rong
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [36] Helicobacter pylori infection as a risk factor for diabetes: a meta-analysis of case-control studies
    Mansori, Kamyar
    Moradi, Yousef
    Naderpour, Sara
    Rashti, Roya
    Moghaddam, Ali Baradaran
    Saed, Lotfolah
    Mohammadi, Hedyeh
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [37] The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
    Miri, Amir Hossein
    Kamankesh, Mojtaba
    Llopis-Lorente, Antoni
    Liu, Chenguang
    Wacker, Matthias G.
    Haririan, Ismaeil
    Asadzadeh Aghdaei, Hamid
    Hamblin, Michael R.
    Yadegar, Abbas
    Rad-Malekshahi, Mazda
    Zali, Mohammad Reza
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] Gastric cancer, Helicobacter pylori infection and other risk factors
    Fuccio, Lorenzo
    Eusebi, Leonardo Henry
    Bazzoli, Franco
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (09) : 342 - 347
  • [39] Serum Antibody Against Helicobacter pylori FlaA and Risk of Gastric Cancer
    Tian, Wenjing
    Jia, Yunhe
    Yuan, Kexin
    Huang, Lina
    Nadolny, Christina
    Dong, Xiaoqun
    Ren, Xiyun
    Liu, Jingjing
    HELICOBACTER, 2014, 19 (01) : 9 - 16
  • [40] A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection
    Kountouras, Jannis
    Doulberis, Michael
    Papaefthymiou, Apostolis
    Polyzos, Stergios A.
    Vardaka, Elizabeth
    Tzivras, Dimitri
    Dardiotis, Efthimios
    Deretzi, Georgia
    Giartza-Taxidou, Evaggelia
    Grigoriadis, Savas
    Katsinelos, Panagiotis
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1452 (01) : 12 - 17